Filing Details
- Accession Number:
- 0000899243-22-016638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-04 17:09:28
- Reporting Period:
- 2022-05-02
- Accepted Time:
- 2022-05-04 17:09:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643921 | N. Sangeeta Bhatia | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-02 | 40 | $255.40 | 6,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 280 | $257.51 | 6,320 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 120 | $258.90 | 6,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 120 | $259.75 | 6,080 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 80 | $260.82 | 6,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 91 | $261.91 | 5,909 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 6 | $264.37 | 5,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
- Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $257.51 (range $257.15 to $258.09).
- Open market sales reported on this line occurred at a weighted average price of $258.90 (range $258.32 to $259.19).
- Open market sales reported on this line occurred at a weighted average price of $259.75 (range $259.35 to $260.14).
- Open market sales reported on this line occurred at a weighted average price of $260.82 (range $260.49 to $261.15).
- Open market sales reported on this line occurred at a weighted average price of $261.91 (range $261.69 to $262.09).
Billionaire Hedge Funds
